- Home
- FOSL vs WHWK Comparison
FOSL vs WHWK Comparison
Compare FOSL & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOSL
- WHWK
- Stock Information
- Founded
- FOSL 1984
- WHWK 2007
- Country
- FOSL United States
- WHWK United States
- Employees
- FOSL N/A
- WHWK N/A
- Industry
- FOSL Consumer Specialties
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- FOSL Consumer Discretionary
- WHWK Health Care
- Exchange
- FOSL Nasdaq
- WHWK Nasdaq
- Market Cap
- FOSL 100.0M
- WHWK 82.4M
- IPO Year
- FOSL 1993
- WHWK N/A
- Fundamental
- Price
- FOSL $3.02
- WHWK $1.86
- Analyst Decision
- FOSL Strong Buy
- WHWK
- Analyst Count
- FOSL 1
- WHWK 0
- Target Price
- FOSL $5.00
- WHWK N/A
- AVG Volume (30 Days)
- FOSL 787.1K
- WHWK 120.2K
- Earning Date
- FOSL 11-06-2025
- WHWK 11-15-2025
- Dividend Yield
- FOSL N/A
- WHWK N/A
- EPS Growth
- FOSL N/A
- WHWK N/A
- EPS
- FOSL N/A
- WHWK N/A
- Revenue
- FOSL $1,083,797,000.00
- WHWK $21,596,000.00
- Revenue This Year
- FOSL N/A
- WHWK N/A
- Revenue Next Year
- FOSL N/A
- WHWK N/A
- P/E Ratio
- FOSL N/A
- WHWK N/A
- Revenue Growth
- FOSL N/A
- WHWK N/A
- 52 Week Low
- FOSL $0.86
- WHWK $1.39
- 52 Week High
- FOSL $3.58
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- FOSL 58.81
- WHWK 53.96
- Support Level
- FOSL $2.90
- WHWK $1.78
- Resistance Level
- FOSL $3.44
- WHWK $2.04
- Average True Range (ATR)
- FOSL 0.20
- WHWK 0.09
- MACD
- FOSL -0.05
- WHWK 0.02
- Stochastic Oscillator
- FOSL 30.00
- WHWK 45.45
About FOSL Fossil Group Inc.
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.